Elekta (EKTA) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
27 Aug, 2026Executive summary
Profitability improved significantly in Q1, with adjusted EBIT margin rising to 11.2% from 6.5% year-over-year, driven by a new operating model, cost savings exceeding SEK 500 million, and lower selling/admin costs.
Net sales declined 2% year-over-year, mainly due to lower sales in APJ, China, and TIMEA, while Americas and Europe showed growth.
Order intake increased for the third consecutive quarter, with a book-to-bill ratio of 1.11, supporting future revenue growth.
The company reaffirmed its full-year guidance for 2%-4% net sales growth and 12.5%-13.5% adjusted EBIT margin, focusing on sustainable margin expansion and operational excellence.
The new regional P&L structure and operating model were fully implemented, aligning reporting with internal management.
Financial highlights
Net sales: SEK 3,536M, down 2% year-over-year; adjusted gross margin rose to 42.6% (from 37.0%), aided by software, services, price increases, and a US tariff refund.
Adjusted EBIT increased 68% to SEK 395M (235), with net income up 146% to SEK 261M (106); adjusted EPS was SEK 0.69 (up from SEK 0.31).
Free cash flow before dividends and M&A improved by SEK 154M year-over-year to SEK -266M, despite higher seasonal inventory build and lower R&D investments.
Gross margin benefited from SEK 53M in US tariff refunds (150 bps impact), with further refunds expected in Q2.
Negative FX impact reduced gross margin by 20 bps and EBIT margin by 30 bps.
Outlook and guidance
Full-year 2026/27 outlook reiterated: net sales growth of 2%-4% in constant currency and adjusted EBIT margin of 12.5%-13.5%.
Q2 expected to return to positive sales growth, with all regions anticipated to grow, led by TIMEA and Americas.
Growth expected from all regions and services, with improved pricing and cost efficiencies.
Market recovery in China and continued momentum in the US support the outlook.
Latest events from Elekta
- Turnaround plan targets mid-single digit sales growth and 14–16% EBIT margin by FY28/29.EKTA
CMD 2026 - Profitability and cash flow surged on cost savings, despite SEK sales decline and impairments.EKTA
Q4 25/26 - Adjusted gross margin rose to 38.3% as restructuring to yield SEK 500M+ savings from Q1.EKTA
Q3 25/26 - AI-driven adaptive radiotherapy and unified software drive adoption, margin, and upgrade growth.EKTA
Investor update - Sales and margins declined, but new products and cost savings support H2 growth outlook.EKTA
Q2 24/25 - Profitable growth and margin expansion achieved despite Q4 sales decline and inflation.EKTA
Q4 23/24 - Margin expansion, software growth, and asset-light upgrades drive sustainable, profitable growth.EKTA
Investor update - Q4 margin hit a five-year high, but R&D impairment led to a net loss; outlook remains strong.EKTA
Q4 24/25 - Order growth, margin gains, and record cash flow offset US and China weakness; guidance lowered.EKTA
Q3 24/25